Protalix BioTherapeutics (PLX) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,442.00 |
| Dec 31, 2025 | -4,271.00 |
| Sep 30, 2025 | 5,476.00 |
| Jun 30, 2025 | 4,241.00 |
| Mar 31, 2025 | -4,367.00 |
| Dec 31, 2024 | 6,433.00 |
| Sep 30, 2024 | 4,662.00 |
| Jun 30, 2024 | 4,639.00 |
| Mar 31, 2024 | -5,488.00 |
| Dec 31, 2023 | 10,478.00 |
| Sep 30, 2023 | 82,079.00 |
| Jun 30, 2023 | 48,159.00 |
| Mar 31, 2023 | 13,127.00 |
| Dec 31, 2022 | 54,597.00 |
| Sep 30, 2022 | 12,692.00 |
| Jun 30, 2022 | 15,690.00 |
| Mar 31, 2022 | 49,928.00 |
| Dec 31, 2021 | 41,264.00 |
| Sep 30, 2021 | 12,621.00 |
| Jun 30, 2021 | 43,543.00 |
| Mar 31, 2021 | 123,954.00 |
| Sep 30, 2020 | 40,928.00 |
| Jun 30, 2020 | 42,783.00 |
| Mar 31, 2020 | 39,335.00 |
| Mar 31, 2019 | 3,885.00 |
| Dec 31, 2018 | -52,572.00 |
| Sep 30, 2018 | -59,025.00 |
| Jun 30, 2018 | -12,107.00 |
| Mar 31, 2018 | -3,737.00 |
| Dec 31, 2017 | 28,427.00 |
| Sep 30, 2017 | -277.00 |
| Jun 30, 2017 | -25,468.00 |
| Mar 31, 2017 | -35,640.00 |
| Dec 31, 2016 | -11,498.00 |
| Sep 30, 2016 | 61,263.00 |
| Jun 30, 2016 | 120,286.00 |
| Mar 31, 2016 | -116,927.00 |
| Sep 30, 2015 | -36,205.00 |
| Jun 30, 2015 | 42,355.00 |